Results of a prospective randomized trial using DTIC and interferon as adjuvant therapy for stage I malignant melanoma
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 21 (5) , 548-550
- https://doi.org/10.1016/s0748-7983(95)97305-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Predicting survival and recurrence in localized melanoma: A multivariate approachWorld Journal of Surgery, 1992
- Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanomaBritish Journal of Cancer, 1992
- Phase II Study of Interferon α-2a and Dacarbazine in Advanced MelanomaAmerican Journal of Clinical Oncology, 1990
- Individual treatment for malignant melanomaJournal of Surgical Oncology, 1989
- Recombinant interferon alfa-2a in advanced malignant melanoma. a phase i-ii study in combination with dticInternational Journal of Cancer, 1987
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970